Loading...
Orion Nutraceuticals Inc.
ORI.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.40
CA$0.00(0.00%)

Over the last four quarters, Orion Nutraceuticals Inc. achieved steady financial progress, growing revenue from $0.00 in Q3 2023 to $0.00 in Q2 2024. Gross profit stayed firm with margins at N/A in Q2 2024 versus N/A in Q3 2023. Operating income totaled $0.00 in Q2 2024, maintaining a N/A margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$51339.00. Net income dropped to -$50919.00, with EPS at $0.00. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan